Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
SIB Swiss Institute of Bioinformatics | RCV000855704 | SCV000998870 | likely pathogenic | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | 2019-08-13 | criteria provided, single submitter | curation | This variant is interpreted as a Likely pathogenic for Mitochondrial DNA depletion syndrome 6, autosomal recessive. The following ACMG Tag(s) were applied: PM2, PP3, PP1, PM3, PM1-supporting, PS3-supporting. |
Gene |
RCV002272375 | SCV002558127 | pathogenic | not provided | 2019-11-13 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (gnomAD); The majority of missense variants in this gene are considered pathogenic (HGMD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 29282788, 24321534, 21996136, 23714749, 22106832, 24894789, 28776642, 34426522) |
Institute for Medical Genetics and Human Genetics, |
RCV000855704 | SCV002574955 | likely pathogenic | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | 2022-09-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002272375 | SCV004292106 | pathogenic | not provided | 2023-04-19 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 93 of the MPV17 protein (p.Gln93Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with mitochondrial DNA depletion syndrome (PMID: 23714749, 28776642). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 694362). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. |
Institute of Human Genetics, |
RCV000855704 | SCV005368223 | likely pathogenic | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | 2024-06-03 | criteria provided, single submitter | clinical testing | Criteria applied: PM1,PM2,PM3,PP3,PP4 |
Biochemical Molecular Genetic Laboratory, |
RCV000855704 | SCV001469169 | likely pathogenic | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | 2020-02-05 | no assertion criteria provided | clinical testing | |
Gene |
RCV000855704 | SCV002567996 | not provided | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | no assertion provided | literature only |